Background: Probiotics are a potentially effective therapy for inflammatory bowel disease (IBD); IBD is linked to impaired gut microbiota and intestinal immunity. However, the utilization of an antibiotic cocktail (Abx) prior to the probiotic intervention remains controversial. This study aims to identify the effect of Abx pretreatment from dextran sulfate sodium (DSS)-induced colitis and to evaluate whether Abx pretreatment has an enhanced effect on the protection of Clostridium butyricum Miyairi588 (CBM) from colitis.
Results: The inflammation, dysbiosis, and dysfunction of gut microbiota as well as T cell response were both enhanced by Abx pretreatment. Additionally, CBM significantly alleviated the DSS-induced colitis and impaired gut epithelial barrier, and Abx pretreatment could enhance these protective effects. Furthermore, CBM increased the benefit bacteria abundance and short-chain fatty acids (SCFAs) level with Abx pretreatment. CBM intervention after Abx pretreatment regulated the imbalance of cytokines and transcription factors, which corresponded to lower infiltration of Th1 and Th17 cells, and increased Th2 cells.
Conclusions: Abx pretreatment reinforced the function of CBM in ameliorating inflammation and barrier damage by increasing beneficial taxa, eliminating pathogens, and inducing a protective Th2 cell response. This study reveals a link between Abx pretreatment, microbiota, and immune response changes in colitis, which provides a reference for the further application of Abx pretreatment before microbiota-based intervention.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946100 | PMC |
| http://dx.doi.org/10.1186/s12866-024-03251-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CXCR4-directed endoradiotherapy with [Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia.
Theranostics
January 2025
Department of Internal Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Article Synopsis
- Despite improvements in targeted therapy for Acute Myeloid Leukemia (AML), the prognosis remains poor, particularly for patients with relapsed or refractory disease.
- Allogeneic hematopoietic stem cell transplantation (alloSCT) is the main curative option for high-risk patients, but the best conditioning approach is still uncertain for those who are chemotherapy-refractory.
- A study on seven AML patients who received CXCR4-directed endoradiotherapy (ERT) combined with total body irradiation and chemotherapy prior to alloSCT showed promising outcomes, with 6 out of 7 patients achieving response and successful engraftment, offering insights into a potentially effective treatment strategy for advanced cases.
Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
BMC Cancer
November 2024
Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Background: We previously reported in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs), pretreatment higher lactate dehydrogenase (LDH) and absolute (abx) neutrophils as well as lower percent (%) lymphocytes correlated with worse overall survival (OS). In this study we aimed to develop a prognostic signature for HNSCC treated with ICIs using these peripheral blood biomarkers (PBBMs).
Methods: Adults with R/M HNSCC treated with ICIs at our institution from 08/2012 to 03/2021 with pretreatment PBBMs were included.
Multivariable models of outcomes with [Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial.
EClinicalMedicine
November 2024
Medical Oncology Department, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.
Background: [Lu]Lu-PSMA-617 (Lu-PSMA-617) prolonged life in patients with metastatic castration-resistant prostate cancer (mCRPC) in VISION (NCT03511664). However, distinguishing between patients likely and unlikely to respond remains a clinical challenge. We present the first multivariable models of outcomes with Lu-PSMA-617 built using data from VISION, a large prospective phase 3 clinical trial powered for overall survival.
View Article and Find Full Text PDFPrognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study.
EJNMMI Rep
October 2024
Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Article Synopsis
- Node-positive non-small cell lung cancer (NSCLC) presents treatment challenges for patients unsuitable for concurrent chemoradiotherapy, leading to a study on the prognostic value of pretreatment PET parameters in high-risk patients receiving hypofractionated radiotherapy.
- A retrospective analysis of 42 patients from a single institution revealed median progression-free survival (PFS) of 11.5 months and overall survival (OS) of 24.3 months, with variables like SUVmax and ECOG performance status significantly predicting these outcomes.
- Multivariable analysis highlighted SUVmax as a key predictor for PFS and ECOG performance status for OS, with patients in the high total metabolic tumor volume (tMTV) group experiencing significantly poorer
Modification of gut and airway microbiota on ozone-induced airway inflammation.
Sci Total Environ
December 2024
School of Public Health, Xinxiang Medical University, Xinxiang, Henan Province 453003, China. Electronic address:
Article Synopsis
- Ground-level ozone exposure leads to airway inflammation and oxidative stress in mice, highlighting its impact on lung health.
- The study examines the effects of gut and airway microbiota disruptions and changes in airway metabolism as factors contributing to this inflammation.
- Findings suggest that the use of broad-spectrum antibiotics alters microbiota and exacerbates ozone-induced airway inflammation and metabolic disturbances.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!